UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: ABASAGLAR-100eml-Solution-SE-IS-RA

Generated Narrative: RegulatedAuthorization ABASAGLAR-100eml-Solution-SE-IS-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/49703

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000426-00049703,http://ema.europa.eu/fhir/eurdId#1751; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection in cartridge; indication = Behandling av diabetes mellitus hos vuxna, ungdomar och barn från 2 års ålder.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = A10AE04,Centralised procedure,CHMP Rapporteur

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2014-09-09

holder: Organization Eli Lilly Nederland B.V.

Cases

-TypeDate[x]
*First Authorisation2014-09-09